All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-30134290

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	30134290	A98G	RT	gag-pol	HIV Infections	D G C L	View
2	30134290	D67G	RT	gag-pol	HIV Infections	D G C L	View
3	30134290	D67N	RT	gag-pol	HIV Infections	D G C L	View
4	30134290	E138Q	RT	gag-pol	HIV Infections	D G C L	View
5	30134290	F227L	RT	gag-pol	HIV Infections	D G C L	View
6	30134290	G190A	RT	gag-pol	HIV Infections	D G C L	View
7	30134290	G190G	RT	gag-pol	HIV Infections	D G C L	View
8	30134290	G190S	RT	gag-pol	HIV Infections	D G C L	View
9	30134290	H221Y	RT	gag-pol	HIV Infections	D G C L	View
10	30134290	I54V	PR	gag-pol	HIV Infections	D G C L	View
11	30134290	K101E	PR	gag-pol	HIV Infections	D G C L	View
12	30134290	K103K	RT	gag-pol	HIV Infections	D G C L	View
13	30134290	K103N	RT	gag-pol	HIV Infections	D G C L	View
14	30134290	K103S	RT	gag-pol	HIV Infections	D G C L	View
15	30134290	K219E	RT	gag-pol	HIV Infections	D G C L	View
16	30134290	K219K	RT	gag-pol	HIV Infections	D G C L	View
17	30134290	K219N	RT	gag-pol	HIV Infections	D G C L	View
18	30134290	K219Q	RT	gag-pol	HIV Infections	D G C L	View
19	30134290	K219R	RT	gag-pol	HIV Infections	D G C L	View
20	30134290	K70R	RT	gag-pol	HIV Infections	D G C L	View
21	30134290	L210W	RT	gag-pol	HIV Infections	D G C L	View
22	30134290	L74V	RT	gag-pol	HIV Infections	D G C L	View
23	30134290	L90M	PR	gag-pol	HIV Infections	D G C L	View
24	30134290	M184I	RT	gag-pol	HIV Infections	D G C L	View
25	30134290	M184M	RT	gag-pol	HIV Infections	D G C L	View
26	30134290	M184V	RT	gag-pol	HIV Infections	D G C L	View
27	30134290	M230L	RT	gag-pol	HIV Infections	D G C L	View
28	30134290	M41L	RT	gag-pol	HIV Infections	D G C L	View
29	30134290	M46I	PR	gag-pol	HIV Infections	D G C L	View
30	30134290	M46L	PR	gag-pol	HIV Infections	D G C L	View
31	30134290	Q151K	RT	gag-pol	HIV Infections	D G C L	View
32	30134290	Q151L	RT	gag-pol	HIV Infections	D G C L	View
33	30134290	Q151M	RT	gag-pol	HIV Infections	D G C L	View
34	30134290	Q151Q	RT	gag-pol	HIV Infections	D G C L	View
35	30134290	T215F	RT	gag-pol	HIV Infections	D G C L	View
36	30134290	T215I	RT	gag-pol	HIV Infections	D G C L	View
37	30134290	T215N	RT	gag-pol	HIV Infections	D G C L	View
38	30134290	T215S	RT	gag-pol	HIV Infections	D G C L	View
39	30134290	T215T	RT	gag-pol	HIV Infections	D G C L	View
40	30134290	T215V	RT	gag-pol	HIV Infections	D G C L	View
41	30134290	T215Y	RT	gag-pol	HIV Infections	D G C L	View
42	30134290	T69N	RT	gag-pol	HIV Infections	D G C L	View
43	30134290	V106A	RT	gag-pol	HIV Infections	D G C L	View
44	30134290	V106I	RT	gag-pol	HIV Infections	D G C L	View
45	30134290	V108I	RT	gag-pol	HIV Infections	D G C L	View
46	30134290	V108V	RT	gag-pol	HIV Infections	D G C L	View
47	30134290	V75M	RT	gag-pol	HIV Infections	D G C L	View
48	30134290	V82A	PR	gag-pol	HIV Infections	D G C L	View
49	30134290	V82L	PR	gag-pol	HIV Infections	D G C L	View
50	30134290	V90I	RT	gag-pol	HIV Infections	D G C L	View
51	30134290	Y181C	RT	gag-pol	HIV Infections	D G C L	View
52	30134290	Y181V	RT	gag-pol	HIV Infections	D G C L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.